Shobha Kantamneni

Array ( [id] => 6725629 [patent_doc_number] => 20030207941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Method of treating vascular endothelial growth factor mediated vascular disorders' [patent_app_type] => new [patent_app_number] => 10/417466 [patent_app_country] => US [patent_app_date] => 2003-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2041 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207941.pdf [firstpage_image] =>[orig_patent_app_number] => 10417466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7257224 [patent_doc_number] => 20050143468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Method of treating vascular endothelial growth factor mediated vascular disorders' [patent_app_type] => utility [patent_app_number] => 10/511414 [patent_app_country] => US [patent_app_date] => 2003-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2018 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20050143468.pdf [firstpage_image] =>[orig_patent_app_number] => 10511414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12015784 [patent_doc_number] => 09808471 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-07 [patent_title] => 'Nasal pharmaceutical formulations and methods of using the same' [patent_app_type] => utility [patent_app_number] => 10/414682 [patent_app_country] => US [patent_app_date] => 2003-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8493 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10414682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7386878 [patent_doc_number] => 20040029841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Purinergic antagonists for treating depression' [patent_app_type] => new [patent_app_number] => 10/413912 [patent_app_country] => US [patent_app_date] => 2003-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1558 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029841.pdf [firstpage_image] =>[orig_patent_app_number] => 10413912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678993 [patent_doc_number] => 20030229134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Methods for stimulating nervous system regeneration and repair by inhibiting phosphodiesterase type 4' [patent_app_type] => new [patent_app_number] => 10/414506 [patent_app_country] => US [patent_app_date] => 2003-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17082 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20030229134.pdf [firstpage_image] =>[orig_patent_app_number] => 10414506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7303183 [patent_doc_number] => 20040115160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Quaternary ammonium esters for disinfection and preservation' [patent_app_type] => new [patent_app_number] => 10/412796 [patent_app_country] => US [patent_app_date] => 2003-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5526 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115160.pdf [firstpage_image] =>[orig_patent_app_number] => 10412796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7362388 [patent_doc_number] => 20040014777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Remedies for retinal nerve diseases containing 1,2-ethanediol derivatives or salts thereof' [patent_app_type] => new [patent_app_number] => 10/398218 [patent_app_country] => US [patent_app_date] => 2003-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3528 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014777.pdf [firstpage_image] =>[orig_patent_app_number] => 10398218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5727528 [patent_doc_number] => 20060058288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Severe sepsis preventive therapeutic agent' [patent_app_type] => utility [patent_app_number] => 10/510596 [patent_app_country] => US [patent_app_date] => 2003-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24319 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20060058288.pdf [firstpage_image] =>[orig_patent_app_number] => 10510596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740797 [patent_doc_number] => 20030158166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Use of fulvestrant in the treatment of resistant breast cancer' [patent_app_type] => new [patent_app_number] => 10/240656 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7524 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158166.pdf [firstpage_image] =>[orig_patent_app_number] => 10240656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7466822 [patent_doc_number] => 20040198770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Uses for l-tetrahydropalmatine' [patent_app_type] => new [patent_app_number] => 10/406811 [patent_app_country] => US [patent_app_date] => 2003-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4875 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198770.pdf [firstpage_image] =>[orig_patent_app_number] => 10406811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7207572 [patent_doc_number] => 20040087606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Shivering suppression during cooling to lower body temperature' [patent_app_type] => new [patent_app_number] => 10/405301 [patent_app_country] => US [patent_app_date] => 2003-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5135 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087606.pdf [firstpage_image] =>[orig_patent_app_number] => 10405301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7387838 [patent_doc_number] => 20040029965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Formulations for reducing or eliminating toxicity of enviromental hormones containing ursodeoxycholic acid' [patent_app_type] => new [patent_app_number] => 10/398057 [patent_app_country] => US [patent_app_date] => 2003-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10216 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029965.pdf [firstpage_image] =>[orig_patent_app_number] => 10398057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7191203 [patent_doc_number] => 20040204486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Anandamide and structurally related lipids as vanilloid receptor modulators' [patent_app_type] => new [patent_app_number] => 10/403527 [patent_app_country] => US [patent_app_date] => 2003-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15164 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 475 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20040204486.pdf [firstpage_image] =>[orig_patent_app_number] => 10403527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6679004 [patent_doc_number] => 20030229145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Pain treatment methods and compositions' [patent_app_type] => new [patent_app_number] => 10/402129 [patent_app_country] => US [patent_app_date] => 2003-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10561 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20030229145.pdf [firstpage_image] =>[orig_patent_app_number] => 10402129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7362426 [patent_doc_number] => 20040014782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Combination therapy for the treatment of diseases involving inflammatory components' [patent_app_type] => new [patent_app_number] => 10/401113 [patent_app_country] => US [patent_app_date] => 2003-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 90375 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014782.pdf [firstpage_image] =>[orig_patent_app_number] => 10401113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7290967 [patent_doc_number] => 20040110732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Pharmaceutical composition for transdermal or transmucosal administration comprising at least one progestin and/or at least one oestrogen, process for preparing it and uses thereof' [patent_app_type] => new [patent_app_number] => 10/393077 [patent_app_country] => US [patent_app_date] => 2003-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4951 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110732.pdf [firstpage_image] =>[orig_patent_app_number] => 10393077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7270337 [patent_doc_number] => 20040058855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Use of materials having zinc ionophoric behavior' [patent_app_type] => new [patent_app_number] => 10/392104 [patent_app_country] => US [patent_app_date] => 2003-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20476 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20040058855.pdf [firstpage_image] =>[orig_patent_app_number] => 10392104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7295158 [patent_doc_number] => 20040213856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Compositions and methods for treatment of multiple myeloma' [patent_app_type] => new [patent_app_number] => 10/258663 [patent_app_country] => US [patent_app_date] => 2003-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2050 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20040213856.pdf [firstpage_image] =>[orig_patent_app_number] => 10258663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7430312 [patent_doc_number] => 20040001895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Combination treatment for depression and anxiety' [patent_app_type] => new [patent_app_number] => 10/388383 [patent_app_country] => US [patent_app_date] => 2003-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21046 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0001/20040001895.pdf [firstpage_image] =>[orig_patent_app_number] => 10388383 [rel_patent_id] =>[rel_patent_doc_number] =>)